Stay up-to-date
Follow us on social media
Latest news
Grifols’ Board of Directors Announces Termination of Acquisition Discussions with Brookfield
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Grifols Delivers Strong Third-Quarter Performance Led by Biopharma 12.1% Growth
Media contacts
Journalist or media professional?
Our media relations team can be reached at:
(+34) 93 571 00 02
media@grifols.com.
Restricted to media inquiries only.
Not a journalist?
For general questions and requests, please contact corporatecomms@grifols.com.
Press Releases
Stay up-to-date on corporate developments as well as innovations in our plasma-derived medicines and other products and solutions.
Company Statements
Our official position on important matters.